We stand at a historical turning point. For 200,000 years, the human lifespan has been strictly limited by biological decay to a maximum of approximately 120 years. Throughout our history, death was an unavoidable biological terminal. Today, we have entered an era where institutional science treats biological attrition not as an inevitability, but as a technical challenge that can be solved through the synthesis of biotechnology and medical intervention.
This report is not a theoretical exercise in radical life extension starting today. Rather, it serves as a navigational instrument for the "Bridge"—the specific strategy required to sustain biological and fiscal integrity long enough to reach the first adoption wave of biotechnology. We are moving from a state of biological inevitability to one of strategic optionality.
The central pillar of this roadmap is the achievement of Longevity Escape Velocity. Consider your remaining lifespan as a fuel tank. Under standard biological conditions, you consume "fuel" at a constant rate as you age. However, LEV occurs when medical breakthroughs add more than one year of life expectancy for every year that passes. When your rate of metabolic repair outpaces your rate of biological decay, you are effectively outrunning the aging process—similar to a rocket achieving the velocity necessary to escape planetary gravity.
The 2026 Horizon Report provides the benchmarks for this transition, analyzing regional readiness, capital endurance horizons, and the specific technological sequences projected to materialize before the 2032 singularity window.
Get the 2026 Horizon Report Today